


Health Ministry restricts the manufacture, sale or distribution of two Fixed Dose Combinations of Naproxen subject to certain conditions
The Ministry of Health and Family Welfare (“MoHFW”) has implemented restriction on the... Read More
Health Ministry permits import of drugs through Cochin and Thiruvananthapuram airports
The Ministry of Health and Family Welfare (“MoHFW”) has notified the Drugs (Third Amendment)... Read More
Department of Pharmaceuticals mandates self-declaration for compliance with new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) by 30th June, 2024
The Department of Pharmaceuticals has directed pharmaceutical companies to submit self-declaration... Read More
Stakeholders in medical devices sector urged by CDSCO to ensure timely payment of retention fees to maintain validity of licenses and certificates
The Central Drugs Standard Control Organisation (“CDSCO”) has reiterated that licenses for... Read More